Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study ; volume:120 ; number:11 ; day:7 ; month:5 ; year:2019 ; pages:1033-1036 ; date:5.2019
British journal of cancer ; 120, Heft 11 (7.5.2019), 1033-1036, 5.2019
- Creator
-
Pinato, David J.
Mauri, Francesco A.
Spina, Paolo
Cain, Owen
Siddique, Abdul
Goldin, Robert
Victor, Stephane
Pizio, Corinna
Akarca, Ayse U.
Boldorini, Renzo L.
Mazzucchelli, Luca
Black, James R. M.
Shetty, Shishir
Marafioti, Teresa
Sharma, Rohini
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-019-0466-x
- URN
-
urn:nbn:de:101:1-2019110909133652155084
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pinato, David J.
- Mauri, Francesco A.
- Spina, Paolo
- Cain, Owen
- Siddique, Abdul
- Goldin, Robert
- Victor, Stephane
- Pizio, Corinna
- Akarca, Ayse U.
- Boldorini, Renzo L.
- Mazzucchelli, Luca
- Black, James R. M.
- Shetty, Shishir
- Marafioti, Teresa
- Sharma, Rohini
- SpringerLink (Online service)
Other Objects (12)
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
Immunohistochemical Analysis of Foxp3+, CD4+, CD8+ Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients
A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis
Correlation of PD-L1 expression with different clinico-pathological and immunohistochemical features of ovarian surface epithelial tumors
Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
Immunohistochemical Analysis of Foxp3+, CD4+, CD8+ Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients
A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis
Correlation of PD-L1 expression with different clinico-pathological and immunohistochemical features of ovarian surface epithelial tumors
Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
PD-L1+ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
Immunohistochemical Analysis of Foxp3+, CD4+, CD8+ Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients
A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis
Correlation of PD-L1 expression with different clinico-pathological and immunohistochemical features of ovarian surface epithelial tumors